Prometheon Pharma careers

Platform technology eliminating 40-50 insulin injections per week for patients, and 14 billion needles per year from this planet. Other applications include growth hormone, hair growth, and potentially vaccines. Patches are stable at room temperature, allowing access to developing regions.

Business model generates revenue long before the product is approved via fee-for-service/CRO model and outlicensing.

Our platform technology allows large therapeutic biomolecules to cross passively through the skin, a convenient and painless alternative to frequent injections and the first patches that are resistant to heat and allow perishable drugs to be activated only upon application.

Prometheon Pharma's Business Plan: app.box.com/s/79vbof3cfleecewpiwl4